Stereotactic Surgery Devices Market Size & Share, by Product (Gamma Knife, LINAC, Proton Beam Radiation Therapy (PBRT), CyberKnife); Application (Liver, Breast, Prostate, Lung, Colon); End-Use (Hospitals, Laboratories) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5331
  • Published Date: Oct 19, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Stereotactic Surgery Devices Market size is poised to reach USD 44 Billion by the end of 2036, growing at a CAGR of 5.7% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of stereotactic surgery devices was USD 26 Billion. The reason behind the growth is due to the rising cases of cancer across the globe. Stereotactic radiosurgery, such as Gamma Knife, is a three-dimensional surgical technique and a very precise form of therapeutic radiation that is often used to treat noncancerous (benign), cancerous (malignant) brain tumors, and also to treat small, early-stage lung cancer and pancreatic cancer, or cancers that have spread to the lung, liver, or adrenal gland.

For instance, Cancer is one of the world's top causes of death, accounting for more than 9 million deaths in 2020, and it is anticipated that by 2040, there will be more than 27 million new cancer cases worldwide.

The growing technological advancements are believed to fuel the market growth. Stereotactic radiation is constantly being improved, owing to technological advances that aid in boosting treatment precision.

Stereotactic Surgery Devices Market Overview
Get more information on this report: Request Free Sample PDF

Stereotactic Surgery Devices Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising Popularity of Minimally Invasive Procedures – Stereotactic surgery is a minimally invasive method of surgical intervention that uses small scalp incisions to provide a safer alternative to traditional brain surgery. Moreover, it employs a three-dimensional coordinate system to pinpoint small objects inside the body without the necessity of a general anesthetic.
  • Growing Popularity of Augmented Reality- Augmented reality (AR) and virtual reality are new technologies and the next stage in the integration of stereotactic navigation into spinal surgery that allows surgeons to view three-dimensional virtual reconstructions of anatomical components placed over the surgical area on a tablet computer. 

Mobile augmented reality will become increasingly popular in the next 2-3 years, with estimates indicating that there will be more than 2 billion mobile AR users worldwide by 2023.


  • High Initial Cost – The development of stereotactic surgery devices incorporates advanced components such as high-resolution imaging systems, and robotic arms which are expensive to produce and also involve high cost of ownership, and cost of surgical setup which may make it difficult for the technology to be adopted by a wider number of laboratories with limited budget. 

Besides this, the market for stereotactic surgery equipment is changing rapidly as a result of extensive research and development activity by leading competitors which usually costs more as these devices require a high level of precision and availability of trained professionals. Furthermore, the high cost of device maintenance also adds to the overall cost.

  • Stringent Rules and Regulations to Obtain Approval for New Stereotactic Surgery Devices
  • Lack of Awareness about the Benefits of Stereotactic Surgery

Stereotactic Surgery Devices Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2023)

~ USD 26 Billion

Forecast Year Market Size (2036)

~ USD 44 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Stereotactic Surgery Devices Segmentation

Application (Liver, Breast, Prostate, Lung, Colon)

The breast segment is estimated to account for 25% share of the global stereotactic surgery devices market in the coming years owing to the rising cases of breast cancer. It is expected that smoking, exposure to carcinogenic substances, changes in other hormones caused by night shift jobs, family history, obesity, and a sedentary lifestyle raise the risk of breast cancer. This has led to an increase in demand for stereotactic surgery devices as stereotactic radiation therapy appears to be promising for elderly women with breast cancer. For instance, The FDA has authorized GammaPod, a novel breast-specific stereotactic body radiotherapy equipment designed to treat breast cancer since it can apply ablative doses with sharp gradients using stereotactic image guidance which means that the tumor receives a high dosage of radiation while the tissues surrounding it receive a considerably lesser dose that reduces the likelihood of side effects.

In 2020, there were more than 7 million women alive who had been diagnosed with breast cancer in the previous five years, making it the world's most common malignancy, which is expected to increase by more than 35% by 2040, to over 2 million cases per year.

Product (Gamma Knife, LINAC, Proton Beam Radiation Therapy (PBRT), CyberKnife)

Stereotactic surgery devices market from the gamma knife segment is set to garner a notable share shortly. Stereotactic radiosurgery, such as Gamma Knife, is a radiation therapy equipment that uses very accurate gamma ray beams to treat a lesion or tumor, and aberrant blood vessel forms in adults and children. Moreover, tumors and other diseases are destroyed with high-energy radiation by employing computer-aided design tools whereby instead of opening the skull to remove a tumor or lesion, gamma radiation beams are used.

Besides this, the LINAC (Linear Accelerator) segment may garner significant share during the forecast timeframe. The LINAC is presently the most often utilized device for conventional radiation and radiosurgery delivery that is becoming more common as a method of radiation therapy for cerebral arteriovenous malformations (AVMs). During treatment, the LINAC equipment moves and rotates around the target to provide radiation beams from various angles and is known as the most widely used method for delivering stereotactic radiosurgery and stereotactic body radiotherapy, respectively which is a non-surgical radiation therapy that is used to treat functional impairments and tiny brain tumors.

Our in-depth analysis of the global stereotactic surgery devices market includes the following segments:


  • Gamma Knife
  •  Proton Beam Radiation Therapy (PBRT)
  • CyberKnife


  • Liver
  •  Breast
  • Prostate
  • Lung
  • Colon


  • Hospitals
  • Laboratories

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Stereotactic Surgery Devices Industry - Regional Synopsis

North American Market Forecast

Stereotactic surgery devices market in North America is predicted to account for the largest share of 42% by 2036 impelled by the rising government initiative to increase cancer awareness. Recently 50 new actions and commitments to end cancer were announced by the President of the United States to decrease the cancer death rate and to prevent more than 3 million cancer deaths by 2047. For instance, The American Cancer Society (ACS) will develop a new curriculum and certification program for oncology professional navigators to support individuals with cancer which is an essential component in clinical settings to improve cancer outcomes in the United States, by ensuring that every cancer patient obtains timely, high-quality, and culturally competent care.

APAC Market Statistics

The APAC stereotactic surgery devices market is estimated to be the second largest, during the forecast timeframe led by growing medical tourism. India has evolved as a medical tourism hotspot that provides patients from all over the world with affordable, high-quality healthcare services.  Moreover, India was ranked 10th in the 2020-2021 Medical Tourism Index, and its reputation as a top destination for medical treatments is projected to rise in the future years. This can lead to an increase in the demand for stereotactic surgery devices in the region.

For instance, more than 1 million patients from over 75 countries visit India each year for medical, wellness, and IVF treatments, generating roughly USD 5 billion for the business, which is predicted to grow to around USD 12 billion by 2026.

Research Nester
Stereotactic Surgery Devices Market Region
Get more information on this report: Request Free Sample PDF

Companies Dominating the Stereotactic Surgery Devices Landscape

    • Koninklijke Philips N.V.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Hitachi Medical Systems
    • Huiheng Group
    • Siemens AG
    • Elekta AB
    • Varian Medical Systems
    • IBA
    • Accuray Incorporated
    • GE Healthcare
    • Toshiba Energy Systems & Solutions Corporation

In the News

  • Siemens AG announced to acquisition of Varian Medical Systems, Inc. to create a highly integrated portfolio of imaging, laboratory diagnostics, and artificial intelligence for the treatment of cancer, and establish a strong and trusted partner capable of supporting customers and patients across the entire cancer care. Furthermore, the acquisition will enable the company to address the growing need for personalized, data-driven diagnosis and precision cancer care and support oncology clinicians and patients in achieving better outcomes.
  • Varian Medical Systems, Inc. announced that it has obtained clearance from the FDA for the use of the first linear accelerators TrueBeam and Edge systems that are intended to accurately target tumors and other diseases using radiation. Furthermore, TrueBeam and Edge systems will be used to treat medically refractory essential tremors with stereotactic radiosurgery to improve the lives of many patients who might otherwise be forced to live with untreatable essential tremors.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5331
  • Published Date: Oct 19, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising cases of cancer across the globe and growing technological advancements are the major factors driving the growth of the market.

The market size of Stereotactic Surgery Devices is anticipated to attain a CAGR of 5.7% over the forecast period, i.e., 2024-2036.

The major players in the market are Hitachi Medical Systems, Huiheng Group, Siemens AG, Elekta AB, Varian Medical Systems, IBA, Accuray Incorporated, GE Healthcare, and others.

The breast segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Stereotactic Surgery Devices Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying